Parkinsonian side effects induced by a monoamine oxidase inhibitor

  • J. P. Teusink
  • , G. S. Alexopoulos
  • , C. A. Shamoian

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

A 75-year-old depressed woman treated with the monoamine oxidase inhibitor (MAOI) phenelzine developed a parkinsonian syndrome that remitted after discontinuation of the drug. The authors discuss possible explanations for this unusual phenomenon.

Original languageEnglish
Pages (from-to)118-119
Number of pages2
JournalAmerican Journal of Psychiatry
Volume141
Issue number1
DOIs
StatePublished - 1984

Fingerprint

Dive into the research topics of 'Parkinsonian side effects induced by a monoamine oxidase inhibitor'. Together they form a unique fingerprint.

Cite this